PopVax Begins Phase I Trial of Fridge-Stable RNA Vaccine in Australia

India's PopVax has begun a Phase I trial in Australia of its first fridge-stable RNA vaccine, with the first two volunteers dosed on August 31. The company says its RNA Foundry in Hyderabad can produce a million doses per year.

2026-10-10 ~ 2026-10-11 · 2 related posts

• PopVax's fridge-stable RNA vaccine enters Phase I trial in Australia, first two participants dosed — CatAstro_Piyush · 2026-10-10
• PopVax's AI-designed fridge-stable RNA vaccine enters Phase I human trial — SeyoneC · 2026-10-11